Genzyme exec: Two big problems facing rare-disease biotechs no one talks about

Stephanie Okey, the head of Genzyme's rare disease business in North America, likes to tell the story of a patient who came into the company's Allston manufacturing plant recently to talk about living with Gauchet disease...